Clinical trial
Combination Chemotherapy in Treating Young Patients With Nonmetastatic…
NCT00379457 · European Paediatric Soft Tissue Sarcoma Study Group, Other · Unknown status
Key facts
| NCT number | NCT00379457 |
|---|---|
| Title | Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma |
| Official title | A Protocol For Nonmetastatic Rhabdomyosarcoma [RMS-2005] |
| Lead sponsor | European Paediatric Soft Tissue Sarcoma Study Group, Other |
| Collaborators | Italian Association for Pediatric Hematology Oncology Children's Cancer and Leukaemia Group Dutch Childhood Oncology Group |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | dactinomycin, carboplatin, cyclophosphamide, doxorubicin hydrochloride, etoposide, ifosfamide, topotecan hydrochloride, vincristine sulfate, vinorelbine tartrate, conventional surgery and 1 more |
| Enrollment | 600 |
| Start date | Jun 1, 2006 |
| Primary completion | May 1, 2011 |
| First posted | Sep 21, 2006 |
| Last update posted | Aug 12, 2013 |
| Countries | Austria, Belgium, Denmark, Ireland, Spain, Sweden, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: